We surveyed 15 children with ADHD diagnosed according to the DSM-5 criteria4, aged 11.8 ± 2.8 years old; 13 were males and 2 were females (combined subtype, n=12; inattentive subtype, n=3). The children's ADHD-RS5 scores were assessed by their mother (n=12), father (n=1), or nursing home staff (n=2) from before the emergency declaration (in February or March 2020) to after the emergency declaration (April or May 2020). There were no changes of treating physician, drug type or quantity, or psychotherapy or assessment person from January 2020 to May 2020.
The children's medications were methylphenidate extended-release (18 mg/day, n=2; 27 mg/day, n=1; 36 mg/day, n=1; 54 mg/day, n=1), methylphenidate extended-release and guanfacine (36 mg/day and 1 mg/day, n=1; 27 mg/day and 5 mg/day, n=1; 27 mg/day and 3 mg/day, n=1), atomoxetine (50 mg/day, n=1), guanfacine (1 mg/day, n=1), methylphenidate extended-release and aripiprazole (36 mg/day and 9 mg/day, n=1), guanfacine and aripiprazole (3 mg/day and 3 mg/day, n=1), aripiprazole and risperidone (15 mg/day and 1.5 mg/day, n=1), or a combination of methylphenidate extended-release, atomoxetine, quetiapine and sodium valproate (36 mg/day, 70 mg/day, 750 mg/day and 700 mg/day, n=1) . One subject was drug naïve.
Table 1 summarizes the children's baseline scores and secondary outcomes (ADHD-RS total score, hyper/impulsive subscore and inattentive subscore) from before the emergency declaration (February or March 2020) to after the emergency declaration (April or May 2020). A comparison of the baseline scores and secondary outcomes reveals that the ADHD-RS total score and inattentive subscore worsened significantly during this period, whereas the hyper/impulsive subscore did not.
Table 1.
Baseline scores and secondary outcomes from before (February/March 2020) to after (April/May 2020) the April 7th emergency declaration in ADHD subjects
|
Feb./March 2020
|
April/May 2020
|
p-value (df, t scores)
|
ADHD-RS Total Score
|
21.9 ± 10.8
|
26.9 ± 10.5
|
0.004* (14, −3.47)
|
ADHD-RS Hyper/Impulsive Subscore
|
8.5 ± 7.3
|
9.9 ± 6.9
|
0.052 (14, −2.13)
|
ADHD-RS Inattentive Subscore
|
13.4 ± 4.8
|
16.9 ± 4.8
|
0.002* (14, −3.73)
|
The data are mean ± SD. Paired Student's two-tailed t-test was used to compare changes from the baseline (before) to after the emergency declaration. *p<0.05.
|
To our knowledge, this is the first report demonstrating that inattentive symptoms in children with ADHD worsened after the children were quarantined for COVID-19, even in the absence of treatment changes. It is plausible that the worsened inattentive symptoms in our patients were associated with psychological trauma due to being quarantined. A very recent study6 showed that ADHD symptoms in children significantly worsened in comparison to the baseline state during the COVID-19 outbreak in China and that children’s negative mood state was associated with ADHD symptoms. It was also reported7,8 that children who were isolated or quarantined during pandemic diseases were more likely to develop acute stress disorder, adjustment disorder, and grief. Moreover, 30% of the children who were isolated or quarantined met the clinical criteria for post-traumatic stress disorder.7,8 The prominent clinical responses to traumatic and stressful events include anhedonic and dysphoric symptoms, externalizing angry and aggressive symptoms, or dissociative symptoms,4 including inattentiveness.
A very recent review9 showed that policy-makers should be aware of the equivocal evidence when considering school closures for COVID-19, and that combinations of social distancing measures should be considered. Additionally, one of the main threat of during the COVID-19 quarantine is an increased risk for domestic violence and child maltreatment, especially for children with disabilities, trauma experiences.10 In conclusion, we suggest that policymakers, healthcare providers and families should be mindful of the potential development of inattentiveness among children with ADHD who are quarantined because of COVID-19.